D72.119
Hypereosinophilic syndrome [HES], unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Hypereosinophilic syndrome (HES) is a rare blood disorder characterized by an excessive number of eosinophils, a type of white blood cell, in the bloodstream and tissues. When eosinophils grow and accumulate uncontrollably, they can cause damage to various organs and tissues throughout the body. The unspecified designation indicates that the exact cause or specific type of HES has not been identified. This condition requires careful medical monitoring and management to prevent organ damage and other complications.
Causes & Symptoms
Clinical Causes: Unknown factors (idiopathic cases) where the exact reason for eosinophil overproduction is not identified. Certain genetic mutations that may lead to abnormal eosinophil growth. Underlying health conditions such as autoimmune diseases. Infections, particularly parasitic infections grown resistant to treatment. Malignancies, including certain cancers of the blood or lymphatic system.
Key Symptoms: Fever and chills Fatigue and weakness Persistent cough and shortness of breath Skin rash, itching, or swelling Abdominal pain and swelling Muscle or joint pain Enlarged lymph nodes Weight loss and loss of appetite Abnormal heart sounds or chest pain Neurological symptoms such as numbness or weakness
Diagnostic & Treatment
Diagnosis Path: Diagnosis of hypereosinophilic syndrome involves a combination of medical history, physical examinations, and various tests, including: - Complete blood count (CBC) to measure eosinophil levels. - Blood smear tests to analyze blood cell morphology. - Imaging studies such as X-ray, ultrasound, MRI, or CT scans to assess organ involvement. - Bone marrow biopsy to evaluate marrow eosinophil production. - Additional tests to rule out secondary causes such as infections or other medical conditions. Finding persistently high eosinophil levels over six months, coupled with evidence of organ damage, supports the diagnosis of HES.
Treatment Protocols: Management of hypereosinophilic syndrome aims to reduce eosinophil levels and prevent tissue damage. Common treatment approaches include: - Corticosteroids, such as prednisone, to suppress eosinophil production. - Targeted therapies, including tyrosine kinase inhibitors, especially in cases involving genetic mutations. - Immunosuppressive drugs to control immune system activity. - Treatment of underlying causes if identified, such as infections or malignancies. - Regular monitoring of blood counts and organ function to assess treatment response and disease progression. - Supportive care for symptoms and organ-specific complications. Since HES varies widely among individuals, treatment plans are tailored to each patient’s specific needs and may involve a multidisciplinary medical team.
Clinical Advice & FAQs
Billing Guidance
Is D72.119 a billable ICD-10 code?
Yes, D72.119 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D72.119?
Clinical documentation must specify the nature of Hypereosinophilic syndrome [HES], unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference